Navigation Links
ShangPharma Independent Committee Appoints Financial Advisor
Date:8/3/2012

SHANGHAI, Aug. 3, 2012 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that the independent committee of the Company's board of directors (the "Independent Committee"), consisting of three of the Company's independent directors, Mr. Yuk Lam Lo, Mr. Julian Ralph Worley and Mr. Benson Tsang, has retained J.P. Morgan Securities (Asia Pacific) Limited ("J.P. Morgan") as its financial advisor.

As the Independent Committee's financial advisor, J.P. Morgan will, together with O'Melveny & Myers LLP ("O'Melveny"), the Independent Committee's legal advisor, assist the Independent Committee in reviewing and evaluating the July 6, 2012 non-binding proposal from the Company's Chairman and Chief Executive Officer, Mr. Michael Xin Hui, and entities affiliated with him (collectively, the "Founder") and TPG Star Charisma Limited and its affiliates (collectively, "TPG") to acquire all of the outstanding shares of ShangPharma not currently owned by the Founder or TPG (the "Proposal"). J.P. Morgan and O'Melveny will also assist the Independent Committee in reviewing and evaluating any additional proposals that may be made by the Founder, TPG or other parties, if any.

The Independent Committee is continuing its evaluation of the Proposal. There can be no assurance that any definitive offer will be made, that any definitive agreement will be executed, that the Independent Committee will recommend the Proposal or that this or any other transaction will be consummated.

About ShangPharma Corporation

ShangPharma Corporation (NYSE: SHP) is a leading China-based contract research organization providing high-quality and cost-effective services for the pharmaceutical and biotechnology industry. It offers a broad range of high-quality, integrated services across the drug discovery and development process to help international and Chinese pharmaceutical and biotechnology companies discover and develop novel drug candidates efficiently. ShangPharma's services consist of discovery chemistry, discovery biology and preclinical development, pharmaceutical development and biologics services. For more information, please visit www.shangpharma.com.

Safe Harbor: Forward-Looking Statements

Certain statements contained in this announcement may be viewed as "forward-looking statements" within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual performance, financial condition or results of operations of the Company to be materially different from any future performance, financial condition or results of operations implied by such forward-looking statements. The accuracy of these statements may be impacted by a number of business risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. The Company undertakes no ongoing obligation, other than that imposed by law, to update these statements.

For further information, please contact:

ShangPharma Corporation
William Dai
Chief Financial Officer
E-mail: IR@shangpharma.com  

Brunswick Group
Josh Gartner
E-mail: shangpharma@brunswickgroup.com
Phone: 86-10-5960-8600


'/>"/>
SOURCE ShangPharma Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. ShangPharma Corporation Files 2011 Annual Report on Form 20-F
2. ShangPharma to Report First Quarter 2012 Financial Results on May 17, 2012
3. ShangPharma Announces First Quarter 2012 Results
4. ShangPharma Announces Receipt of "Going Private" Proposal at $8.50 to $9.50 Per ADS
5. ShangPharma Independent Committee Appoints Chairman and Legal Counsel
6. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
7. EnerJel™ Adds 200 Independent Pharmacies To Distribution Base
8. Allscripts Adds Two Independent Directors to Board
9. American Oriental Bioengineering Announces Change of Independent Auditors
10. Cardinal Health Celebrates Community Pharmacists Commitment to Patient Care at Annual Trade Show for Independent Pharmacies
11. Cardinal Health Highlights Independent Pharmacy Best Practices At Retail Business Conference 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/28/2020)... ... January 28, 2020 , ... According to the American Transplant Foundation, ... 30% will receive their life-saving surgery this year. Unfortunately, 20 people will die each ... 40,000. This is not from a lack of available donated organs, but mainly ...
(Date:1/28/2020)... ... January 28, 2020 , ... Knowing it can be difficult ... healthy changes, Isagenix International has launched several offerings, including Snack Bites, ... health and wellness company has also expanded its BEA™ Sparkling Energy Drink and ...
(Date:1/28/2020)... (PRWEB) , ... January 28, 2020 , ... Once a ... speakers offer attendees their unique perspectives, innovative research and professional experiences, unmatched as a ... at the 34th annual iaedp™ Symposium slated for March 26 – 29, is no ...
Breaking Medicine Technology:
(Date:1/27/2020)... ... January 27, 2020 , ... Respected periodontists in Moorestown ... Pinnacle Dental Study Club course of the calendar year on January 29, 2020. The ... courses, hosted by the doctors at Canal Calem Periodontics. , The Pinnacle ...
(Date:1/27/2020)... ... 2020 , ... ConfiDenT is a trusted family, Alpharetta ... at 11550 Webb Bridge Way in Alpharetta, GA 30005, Dr. Cesar Tapia leads ... in general and preventative dentistry, as well as in restorative dentistry, cosmetic dentistry, ...
(Date:1/27/2020)... ... 26, 2020 , ... ResMed Launches AirFit F30i, Its First Tube-up Full Face ... the launch of the AirFit F30i, Its First Tube-up Full Face ResMed CPAP Mask. ... or tube-down connection, compact under-the-nose or traditional over-the-nose cushion styles, and even memory foam ...
(Date:1/24/2020)... ... 24, 2020 , ... Primary Residential Mortgage, Inc. is pleased ... , PRMI was awarded second place in Springbuk’s annual Healthiest Employers awards ... adoption of programs that promote healthy lifestyles, such as biometric screenings, fitness and ...
(Date:1/24/2020)... ... 24, 2020 , ... The new strain of Wuhan coronavirus was first identified ... Thailand, Japan, and South Korea. The virus is believed to have started in the ... were infected. , EPA has confirmed that the 2019 novel coronavirus-Wuhan (also 2019-nCoV) ...
Breaking Medicine News(10 mins):